Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models

Published: Friday, October 12, 2012
Last Updated: Friday, October 12, 2012
Bookmark and Share
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.

The three way collaboration, between TAP Biosystems and researchers on two UCL sites at the Division of Surgery and Interventional Science, will focus on developing technology to generate advanced 3D cancer tissue models for use in research and drug discovery. Their aim is to use TAP’s RAFT™ (Real Architecture for 3D Tissue™) technology to reproduce solid tumour micro architecture, by seeding co-cultures of cancer cells, fibroblasts and endothelial cells into a collagen gel. With the correct conditions, fibroblasts aggregate around the cancer cells to form connective tissue, and the endothelial cells fuse to form lumens, producing angiogenic growth factor and rudimentary vasculature, so that the final co-culture has many of the features and behaviour of a solid tumour.

Dr Marilena Loizidou, Senior Lecturer, Division of Surgery and Interventional Science at
UCL explained:”Our ultimate aim is to engineer reproducible 3D tissues to test the efficacy of compounds and biologics to treat solid tumours in diseases such as breast, bowel and bladder cancer. By engineering these types of tissues, we’ll have a far reaching impact on translational research, as we could more readily tease out the mechanisms of why drugs do or don’t act effectively on tumours.”

Dr Umber Cheema, Research Fellow at the Division of Surgery and Interventional Science at UCL added: “When making 3D cancer tissues it is very difficult to do this in a controlled, reproducible way, and we need help making the tissue formation process consistent for pharma and biotech use. TAP Biosystems is a company that has a proven background, as well as a progressive vision. We believe utilising the RAFT platform is the best way to make our science relevant and are very pleased to be partnering with TAP on this project.”

Dr Rosemary Drake, CSO at TAP Biosystems said: “We are delighted to be extending our collaborative partnerships at UCL to include a new application of the RAFT process. We look forward to working together with Dr Marilena Loizidou and Dr Umber Cheema’s teams of experts to develop novel 3D human tumour models that reproduce the cells’ in vivo environment. Using this approach to create more realistic and complex models, should mean that data are more robust and relevant and drug screening becomes more efficient. This could result in significant cost savings, and, more importantly, may contribute to reducing the amount of pre-clinical animal studies required for testing new oncology therapies.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
How Prions Kill Neurons: New Culture System Shows Early Toxicity to Dendritic Spines
Boston University researchers have developed a cell culture system to study prions.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Bio-Mimicry Method For Preparing & Labeling Stem Cells Developed
Method allows researchers to prepare mesenchymal stem cells and monitor them using MRI.
Stem Cell Advance Could Be Key Step Toward Treating Deadly Blood Diseases
UCLA scientists get closer to creating blood stem cells in the lab.
Harnessing Engineered Slippery Surfaces For Tissue Repair
A new method could facilitate the transfer of intact regenerating cell sheets from the culture dish to damaged tissues in patients.
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Brazilian Zika Virus Strain Causes Birth Defects in Experimental Models
First direct experimental proof of causal effect, researchers say.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!